Journals / Journal of the Turkish-German Gynecological Association / 2018 / Cilt: 19 - Sayı: 2

Pregnancy in papillary thyroid cancer survivors

Pages
94–97
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients who have received papillary thyroid cancer treatment can safely undergo pregnancy. (J Turk Ger Gynecol Assoc 2018; 19: 94-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate “papillary thyroid carcinoma-pregnancy” interaction among cancer survivors.Material and Methods: The clinical records of 8 pregnant women who received treatment for papillary thyroid cancer before their pregnancy were evaluated.
📊
Key Findings & Data:Clinical features, pregnancy/perinatal outcomes and high-risk factors were compared with 45 controls who were randomly assigned from the institutional perinatal medicine database.Results: Patients in the cancer group were older than the control group (34.3 vs 29.8 years).
💡
Conclusion & Impact:Patients who have received papillary thyroid cancer treatment can safely undergo pregnancy. (J Turk Ger Gynecol Assoc 2018; 19: 94-7)
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate “papillary thyroid carcinoma-pregnancy” interaction among cancer survivors.Material and Methods: The clinical records of 8 pregnant women who received treatment for papillary thyroid cancer before their pregnancy were evaluated. Clinical features, pregnancy/perinatal outcomes and high-risk factors were compared with 45 controls who were randomly assigned from the institutional perinatal medicine database.Results: Patients in the cancer group were older than the control group (34.3 vs 29.8 years). The cesarean section rate was higher (62.5% vs 33.3%) and the APGAR scores at the 1st and 5th minutes were lower in the cancer group.Conclusion: Management of pregnancies with papillary thyroid cancer treatment and follow-up requires a multidisciplinary approach with careful antenatal care and perinatal surveillance. Patients who have received papillary thyroid cancer treatment can safely undergo pregnancy. (J Turk Ger Gynecol Assoc 2018; 19: 94-7)

🔖

Cite This Article

ÇELİK, H. T., ÖRGÜL, G., BEKSAÇ, M. S., AKTOZ, F., BEKSAÇ, K., ERDİNÇ, A. S. Ö. (2022). Pregnancy in papillary thyroid cancer survivors. Journal of the Turkish-German Gynecological Association, Cilt: 19 - Sayı: 2, 94–97. https://ajindex.com/articles/567498

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Leenhardt L, Grosclaude P, Cherie-Challine L; Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004; 14: 1056-60
  2. Sungwalee W, Vatanasapt P, Kamsa-Ard S, Suwanrungruang K, Promthet S. Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev 2013; 14: 5153-5
  3. Xhaard C, Rubino C, Clero E, Maillard S, Ren Y, Borson-Chazot F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol 2014; 180: 1007-17
  4. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128-35
  5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29
  6. Imran SA, Rajaraman M. Management of differentiated thyroid cancer in pregnancy. J Thyroid Res 2011; 2011: 549609
  7. Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. Optimal timing of surgery for differentiated thyroid cancer in pregnant women. World J Surg 2014; 38: 704-8
  8. Cabezon CA, Carrizo LC, Costanzo PR. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina. Arq Bras Endocrinol Metabol 2013; 57: 307-11
  9. Budak A, Gulhan I, Aldemir OS, Ileri A, Tekin E, Ozeren M. Lack of influence of pregnancy on the prognosis of survivors of thyroid cancer. Asian Pac J Cancer Prev 2013; 14: 6941-3
  10. Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 2014; 24: 840-4
  11. Lee JC, Zhao JT, Clifton-Bligh RJ, Gill AJ, Gundara JS, Ip J, et al. Papillary thyroid carcinoma in pregnancy: a variant of the disease? Ann Surg Oncol 2012; 19: 4210-6
  12. Sioka C, Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril 2011; 95: 1552-9
  13. Grammatikakis I, Trakakis E, Evangelinakis N, Hintipas E, Salamalekis G, Kassanos D. Successful pregnancy after radiotherapy with 131I for differentiated thyroid cancer. A case report and review of the literature. Clin Exp Obstet Gynecol 2010; 37: 328-30
  14. Momotani N, Iwama S. [Management of Graves' disease and hypothyroid